Oppenheimer & Co’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-43,974
Closed -$326K 1581
2021
Q1
$326K Buy
+43,974
New +$356K 0.01% 1135
2017
Q1
Sell
-11,550
Closed -$190K 1366
2016
Q4
$190K Sell
11,550
-3,225
-22% -$56.8K 0.01% 1166
2016
Q3
$298K Buy
14,775
+400
+3% +$7.95K 0.01% 992
2016
Q2
$224K Buy
14,375
+3,600
+33% +$74.6K 0.01% 1056
2016
Q1
$303K Sell
10,775
-250
-2% -$11.8K 0.01% 936
2015
Q4
$675K Buy
+11,025
New +$670K 0.02% 678

Other funds holding ENDP

Oppenheimer & Co's ENDP Position: Q2 2021 in Review

Oppenheimer & Co sold out of Endo International plc (ENDP) in Q2 2021, closing a stake of 43,974 shares — an estimated $326K sold.

Oppenheimer & Co first reported a position in ENDP in Q4 2015 and held it in 6 quarters. The position peaked at $675K in Q4 2015. 203 funds tracked by Wall St. Rank hold ENDP as of Q2 2021.

  • Oppenheimer & Co reported no remaining Endo International plc position as of Q2 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 43,974 Endo International plc shares in Q2 2021, an estimated $326K.
  • Oppenheimer & Co first reported a position in Endo International plc in Q4 2015 and held it in 6 quarters.
  • Oppenheimer & Co's Endo International plc position peaked at $675K in Q4 2015.
  • 203 funds tracked by Wall St. Rank held Endo International plc as of Q2 2021.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.